Inari Medical is the global leader in venous clot removal having developed three thrombectomy technology platforms for the treatment of venous thrombosis. Funded by prestigious venture capital firms, Gilde Healthcare, Versant Ventures, and U.S. Venture Partners, Inari debuted as the Best U.S. IPO of 2020 and generated $235M in revenue in 1H 2023 with a 31% increase from 2022. Oh, and Inari Medical is named after a piece of sushi…inari sushi. Inari is hiring their Head of Quality Engineering.
We have partnered with Kit Cariquitan, Vice President of Quality Assurance and Regulatory Affairs, to hire our Head of Quality Engineering. This position will be a strategic and tactical leader across Quality Engineering groups while leading new product development and sustainment activities. This position will lead cross-functionally with R&D and Engineering teams ensuring risk management and design control processes are met while leading GAP remediations. Our Head of QE will also develop and manage a team.
Inari Medical, Inc. is a publicly traded medical device company dedicated to the development of innovative catheter-based technologies for the treatment of venous thromboembolism. Inari is focused on solutions that enable the safe removal of large clot volumes from big vessels without the use of thrombolytic drugs. Inari has developed three novel mechanical thrombectomy technology platforms.
The FlowTriever System has FDA clearance for the treatment of pulmonary embolism and for thrombectomy in the peripheral vessels. The ClotTriever System has FDA clearance for thrombectomy in the peripheral vessels. The InThrill System has FDA clearance for small vein and AV thrombectomy. Inari was founded in 2013 as a spin-out of Inceptus Medical, a medical device incubator.
Company Overview
Lifeblood™ supports global MedTech Startups with Talent Acquisition and Fundraising Strategies. We build full-scale startup teams from Board and C-level executives to entry-level individual contributors and from early-stage R&D through multi-national commercialization phases.Approaching two decades of experience in the MedTech industry, our talent acquisition services and team-building efforts are the results of 2,000+ successful hires for 500+ companies in 6 continents. We have facilitated more than $220 million for MedTech startups with our fundraising strategies and global investor network.
People and money are the lifeblood capital of startups. Learn from our entrepreneurs and investors as we demystify raising and investing capital on our MedTech Money Podcast Series.